ATXS icon

Astria Therapeutics
ATXS

Overview Fund Activity

24 hedge funds and large institutions have $14.1M invested in Astria Therapeutics in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.55%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
5
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.72M
2
Deutsche Bank
2
Deutsche Bank
Germany
$919K
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$255K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.06M
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$25K

Top Sellers

1
CV
1
Clarus Ventures
Massachusetts
$3.64M
2
SFM
2
Sphera Funds Management
Israel
$0
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$213K
4
ARTA
4
A.R.T. Advisors
New York
$0
5
OAM
5
Oxford Asset Management
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
ARTA
26
A.R.T. Advisors
New York
– – -63,436 Closed
OAM
27
Oxford Asset Management
United Kingdom
– – -19,737 Closed
Goldman Sachs
28
Goldman Sachs
New York
– – -16,403 Closed
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
– – -16,303 Closed
Macquarie Group
30
Macquarie Group
Australia
– – -5,197 Closed
CHP
31
Cable Hill Partners
Oregon
– – -500 Closed
1
2